Table 2. BRCA1 testing prescription rate following patient factors and annual breast cancer incidence rate (2010–2013).

	β	SE	p-value*	RR	95% CI		p-value†
					Lower	Upper
Model 1‡
BRCA1 testing	468.743	63.327	0.002	1.341	1.163	1.546	0.056
Model 2§
BRCA1 testing	117.321	37.11	0.005	1.342	1.247	1.444	<0.001
Sex			<0.001				0.019
Male	Reference			Reference
Female	701.083	126.753		0.361	0.172	0.757
Patients			0.024				<0.001
Inpatient	Reference			0.35	0.293	0.418
Outpatient	–310.250	126.753		Reference
Model 3§
BRCA1 testing	234.657	51.137	0.001	-	-	-	-
Area			0.002
Urban cities	Reference			-	-	-	-
Provincial area	–751.333	174.668		-	-	-	-

SE=standard error; RR=relative risk; CI=confidence interval.

^*p-value by Linear regression analysis without adjustment by annual breast cancer incidence; ^†p-value by Poisson regression analysis with adjustment by annual breast cancer incidence; ^‡model observing serial change; ^§model observing serial change adjusted by multiple factors.